Insys Therapeutics (INSY) Tops Q2 EPS by 23c
Tweet Send to a Friend
Insys Therapeutics, Inc. (NASDAQ: INSY) reported Q2 EPS of $0.35 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
